Ad Council

Fraxel Re:pair Laser Approved to Treat Skin Damage

Reliant Technologies received FDA approval for its Fraxel re:pair laser system. Approved indications for the device include ablation, coagulation, and skin resurfacing for patients with skin changes associated with damage or age. Studies reveal collagen remodeling, tissue tightening and contraction with treatment.

The Fraxel system combines technology from fractional photothermolysis and conventional CO2 resurfacing, dubbed Fractional Deep Dermal Ablation (FDDA). This is the first approval of an FDDA system.

The system targets an area of skin with treatment but does not affect tissue that immediately surrounds the treated area, which fosters healing of treated skin. The therapy acomplishes deep penetration in columns up to 1.6 mm deep. This approach can be used to treat delicate skin areas such as the chest and neck.

Related stories:

July 3, 2007 Related topics: Product Launches, Plastic Surgery, Dermatology

Today on
Hospital Buyer

Rate of Health Insurance Increasing

The U.S. Census Bureau issued a report, “Income, Poverty, and Health Insurance Coverage in the United States: 2007″...

Heat Exchange Catheter Cleared for Marketing

Alsius, a company dedicated to the development of products to control patient temperature in critical care, recently announced...

Laser Device Launched by Cutera

The Pearl Fractional system for aesthetic treatments was recently launched by Cutera, Incorporated. The company is targeting the...

McKesson Nets Three Hospital Install with Nueterra

The Paragon clinical/financial community hospital information system from McKesson is the solution of choice for Nueterra Healthcare. The...

http://www.hospitalbuyer.com